Terri Brodeur Breast Cancer Foundation Newsletter - Special Edition
In This Issue
TBBCF Scientific Advisory Committee

Nicholas Saccomano, PhD, Chair

Chief Scientific Officer, Array BioPharma Inc.


John LaMattina, PhD, Co-Chair

Former President, Pfizer Global Research and Development


Michael Garabedian, PhD

Professor and Course Director, New York University Medical Center


Stacey Gualtieri, CPA

President, Doherty,Beals and Banks;

Grants Administrator for the Scientific Advisory Committee


Susan Logan, PhD

Associate Professor, New York University Medical Center


Mike Morin, PhD

President and CEO, Oncovia Therapeutics, Inc.

Past Grant Recipients



Oliver, Andrea MD Dana-Farber Cancer Institute

Chatterjee, Samit PhD Cold Spring Harbor Laboratory

Mayer, Erica MD, MPH Dana-Farber Cancer Institute

Lee, Dongoo PhD Memorial Sloan Kettering



Irie, Hanna Y MD, PhD Mount Sinai School of Medicine

Choudhury, Sibgat PhD Dana-Farber Cancer Institute

Fertuck, Kirsten PhD Dana-Farber Cancer Institute



Bialucha, Carl Uli PhD Cold Spring Harbor Laboratory

Kutuk, Ozgur MD, PhD Dana-Farber Cancer Institute

Bailey, Shannon T. MD Dana-Farber Cancer Institute

Zang, Qing PhD Dana-Farber Cancer Institute Full Listing

January 30, 2015
Keeping Logan's Promise
Norma Logan, co-founder of the Terri Brodeur Breast Cancer Foundation, believed passionately that every fundraising dollar to the Foundation should go directly to breast cancer research.  It is with great pleasure and pride that we announce the TBBCF research grant recipients for 2015. 

Congratulations to the 2015 TBBCF Research Grant Recipients

Click here to read the project summaries and biographies for the 2015 grant recipients.

TBBCF Scientific Advisory Committee Announces 2015 Grant Recipients

Dear TBBCF Supporters, 


Dr. John LaMattina

Everyone has been profoundly impacted in some way by breast cancer. Be it a friend, relative, partner or spouse, this disease causes much sorrow and loss. TBBCF is dedicated to supporting research to find a cure for breast cancer and, thanks to hundreds of walkers, volunteers and sponsors over the last nine years, over $3 million has been raised to facilitate such important new research.


Specifically, TBBCF seeks to fund young researchers in the Northeast who are carrying out groundbreaking science into the causes of breast cancer, its proliferation and methods to treat existing disease. More

Our Scientific Advisory Committee


Dr. Nick Saccomano

The idea of funding breast cancer research requires technical expertise to analyze and develop funding mechanisms, a fluency in the sciences, and especially, a vision of the future: and a gaze toward the novel therapies and people who might unravel the mysteries of breast cancer promoting therapies to combat the disease.


The founding Scientific Advisory Committee (SAC) volunteered to lead this mission while pursuing their own demanding careers as scientists, business leaders, and scientific researchers. In the past nine fundraising years, the SAC has awarded $3M in research dollars to fund new efforts to eradicate breast cancer. 


In the process of granting these monies, they have reviewed over 200 formal proposals and interviewed numerous candidates. Their strategy is to continue to build name recognition in the area and build outward slowly. More


TBBCF |  860.437.1400 | tbbcf@sbcglobal.net | http://tbbcf.org
PO Box 785
New London, CT 06320